The role of IDH1 mutated tumour cells in secondary glioblastomas: an evolutionary game theoretical view
暂无分享,去创建一个
David Basanta | Jacob G. Scott | Jacob G Scott | Alexander R A Anderson | Kristin R Swanson | K. Swanson | R. Rockne | D. Basanta | Russ Rockne | A. Anderson
[1] Christos Davatzikos,et al. An image-driven parameter estimation problem for a reaction–diffusion glioma growth model with mass effects , 2008, Journal of mathematical biology.
[2] K. Mathieson,et al. The value of positron emission tomography and proliferation index in predicting progression in low-grade astrocytomas of childhood , 2009, Journal of Neuro-Oncology.
[3] D. Busam,et al. An Integrated Genomic Analysis of Human Glioblastoma Multiforme , 2008, Science.
[4] Y. Matsukado,et al. The growth of glioblastoma multiforme (astrocytomas, grades 3 and 4) in neurosurgical practice. , 1961, Journal of neurosurgery.
[5] Albert Lai,et al. Prognostic significance of growth kinetics in newly diagnosed glioblastomas revealed by combining serial imaging with a novel biomathematical model. , 2009, Cancer research.
[6] Santosh Kesari,et al. Malignant gliomas in adults. , 2008, The New England journal of medicine.
[7] L. Deangelis,et al. Patterns of relapse and prognosis after bevacizumab failure in recurrent glioblastoma , 2009, Neurology.
[8] E. T. Gawlinski,et al. The glycolytic phenotype in carcinogenesis and tumor invasion: insights through mathematical models. , 2003, Cancer research.
[9] M. Aghili,et al. Hydroxyglutaric aciduria and malignant brain tumor: a case report and literature review , 2008, Journal of Neuro-Oncology.
[10] R. Gillies,et al. Why do cancers have high aerobic glycolysis? , 2004, Nature Reviews Cancer.
[11] A. Deutsch,et al. Evolutionary game theory elucidates the role of glycolysis in glioma progression and invasion , 2008, Cell proliferation.
[12] D. Hanahan,et al. The Hallmarks of Cancer , 2000, Cell.
[13] R. McLendon,et al. IDH1 and IDH2 mutations in gliomas. , 2009, The New England journal of medicine.
[14] M. Westphal,et al. Cost of migration: invasion of malignant gliomas and implications for treatment. , 2003, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.
[15] William C Hahn,et al. Rules for making human tumor cells. , 2002, The New England journal of medicine.
[16] L. Liau,et al. Cancer-associated IDH1 mutations produce 2-hydroxyglutarate , 2009, Nature.
[17] Kristin R. Swanson,et al. The Evolution of Mathematical Modeling of Glioma Proliferation and Invasion , 2007, Journal of neuropathology and experimental neurology.
[18] J. Murray,et al. A quantitative model for differential motility of gliomas in grey and white matter , 2000, Cell proliferation.
[19] P. Maini,et al. Mathematical oncology: Cancer summed up , 2003, Nature.
[20] Kun-Liang Guan,et al. Glioma-Derived Mutations in IDH1 Dominantly Inhibit IDH1 Catalytic Activity and Induce HIF-1α , 2009, Science.
[21] Susan M. Chang,et al. A phase II trial of erlotinib in patients with recurrent malignant gliomas and nonprogressive glioblastoma multiforme postradiation therapy. , 2010, Neuro-oncology.
[22] Jörgen W. Weibull,et al. Evolutionary Game Theory , 1996 .
[23] S. Coons,et al. Dichotomy of astrocytoma migration and proliferation , 1996, International journal of cancer.
[24] M. Nowak,et al. Evolutionary game theory , 1995, Current Biology.
[25] P. Kleihues,et al. IDH1 Mutations as Molecular Signature and Predictive Factor of Secondary Glioblastomas , 2009, Clinical Cancer Research.
[26] A. Unterberg,et al. Different angiogenic phenotypes in primary and secondary glioblastomas , 2006, International journal of cancer.
[27] A. Gregory Sorensen,et al. Angiogenesis in brain tumours , 2007, Nature Reviews Neuroscience.
[28] E. T. Gawlinski,et al. Acid-mediated tumor invasion: a multidisciplinary study. , 2006, Cancer research.